Eyegate Pharmaceuticals Inc. | Balance Sheet
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
501.20
167.00
8,394.10
3,635.20
7,806.00
8,004.20
Total Accounts Receivable
35.10
25.30
932.60
53.80
23.70
18.40
Other Current Assets
22.40
26.40
122.40
465.00
629.60
455.80
Total Current Assets
558.60
218.80
9,449.10
4,154.00
8,459.30
8,478.40
Net Property, Plant & Equipment
3.00
1.30
-
38.00
55.80
43.50
Total Investments and Advances
30.00
-
20.00
45.00
45.00
45
Long-Term Note Receivable
195.00
58.80
58.80
58.80
-
-
Intangible Assets
-
-
-
5,438.20
5,438.20
5,682
Other Assets
100.60
1,186.40
38.60
55.30
307.10
31.70
Total Assets
887.20
1,465.30
9,566.50
9,789.40
14,305.40
14,280.60
ST Debt & Current Portion LT Debt
2,027.20
3,205.50
-
12.60
11.20
Accounts Payable
13.70
-
-
1,412.10
706.10
Other Current Liabilities
530.20
1,818.50
3,420.90
5,883.30
14,116.20
Total Current Liabilities
2,571.20
5,024.00
3,420.90
7,308.10
14,833.50
Long-Term Debt
-
-
-
16.10
4.90
Deferred Taxes
-
-
-
1,525.90
183.90
Other Liabilities
-
-
-
1,210.00
1,210.00
Total Liabilities
2,571.20
5,024.00
3,420.90
10,060.00
16,232.30
Common Equity (Total)
44,648.80
46,748.00
6,145.60
270.60
1,926.90
Total Shareholders' Equity
8,240.20
10,339.30
6,145.60
270.60
1,926.90
Total Equity
1,684.00
3,558.70
6,145.60
270.60
1,926.90
Liabilities & Shareholders' Equity
887.20
1,465.30
9,566.50
9,789.40
14,305.40
Accumulated Minority Interest
6,556.20
6,780.60
-
-
-
Preferred Stock (Carrying Value)
36,408.70
36,408.70
-
-
0.00
About Eyegate Pharmaceuticals
View Profile
